Related Experiment Video
Updated: Oct 28, 2025
05:15
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.8K
HIV vaccinology: 2021 update
Jeong Hyun Lee1, Shane Crotty2
1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
Seminars in Immunology
|July 17, 2021
Summary
Despite decades of research, a cure for Human Immunodeficiency Virus (HIV) remains elusive. This review highlights recent HIV vaccine trials and advancements in prophylactic vaccine design.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Human Immunodeficiency Virus (HIV) infection is a persistent global health challenge with no existing cure.
- Over three decades since its identification, HIV vaccine development remains a critical research priority.
Purpose of the Study:
- To review recent Human Immunodeficiency Virus (HIV) vaccine efficacy trials.
- To discuss advancements in prophylactic HIV vaccine designs.
- To cover clinical trials initiated within the past three years.
Main Methods:
- Literature review of recent HIV vaccine efficacy trials.
- Analysis of clinical trials initiated in the last three years.
- Examination of current prophylactic HIV vaccine designs.
Main Results:
- Summary of findings from recent HIV vaccine efficacy trials.
- Identification of key improvements in prophylactic HIV vaccine strategies.
- Overview of ongoing clinical research in HIV vaccine development.
Conclusions:
- Continued intensive research is crucial for developing an effective HIV vaccine.
- Recent trials and design improvements offer promising directions for future vaccine development.
- Progress in prophylactic vaccine design is essential to combat the HIV epidemic.
More Related Videos
Related Concept Videos
01:51Vaccinations
47.4K
Overview
47.4K
01:30Cancer Vaccines
582
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
582
01:22Development of Immunocompetence
535
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
535
01:29Immune Response Against Viral Pathogens
1.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.1K
01:25Immunodeficiency Diseases
1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.3K
01:23Immunological Memory
11.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
11.9K